Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

26.92
-1.0950-3.91%
Post-market: 26.920.00000.00%19:54 EDT
Volume:1.10M
Turnover:29.82M
Market Cap:1.56B
PE:-11.60
High:28.00
Open:27.64
Low:26.60
Close:28.02
52wk High:40.37
52wk Low:4.30
Shares:57.84M
Float Shares:48.42M
Volume Ratio:1.00
T/O Rate:2.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3214
EPS(LYR):-2.2601
ROE:-56.40%
ROA:-31.23%
PB:5.59
PE(LYR):-11.91

Loading ...

Capricor Therapeutics Inc - Files Lawsuit and Seeks Preliminary Injunction in New Jersey Court on May 7, 2026 - SEC Filing

THOMSON REUTERS
·
May 08

Earning Preview: Capricor Therapeutics this quarter’s revenue is expected to decrease by 100%, and institutional views are bullish

Earnings Agent
·
May 06

Capricor CFO Anthony Bergmann disposes of 25,000 shares worth $792,540

Reuters
·
May 05

Capricor EVP, General Counsel Karen Krasney disposes 25,000 shares for $792,548‬

Reuters
·
May 05

Capricor Therapeutics schedules first-quarter 2026 financial results conference call and webcast

Reuters
·
May 05

Press Release: Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Dow Jones
·
May 05

Capricor Therapeutics (CAPR) Is Down 12.4% After New HOPE-3 Deramiocel Phase 3 Data Release - What's Changed

Simply Wall St.
·
May 03

Capricor reports Phase 3 HOPE-3 trial results for Deramiocel in Duchenne muscular dystrophy

Reuters
·
Apr 22

Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

Capricor Therapeutics (CAPR) Gets a Buy from Roth MKM

TIPRANKS
·
Apr 15

Capricor director Karimah Es Sabar disposes of $0.2 million common shares

Reuters
·
Apr 04

Capricor director Karimah Es Sabar disposes of common shares worth $3.5 million

Reuters
·
Apr 02

Capricor EVP, General Counsel Karen Krasney disposes of CAPR shares worth $0.8 million

Reuters
·
Apr 02

Capricor CFO Anthony Bergmann disposes of $0.8 million in common shares

Reuters
·
Apr 02

Capricor Therapeutics announces annual shareholder meeting, issues proxy statement

Reuters
·
Apr 01

Roth MKM Keeps Their Buy Rating on Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 20

Capricor Therapeutics Nears Key Milestones After Earnings Call

TIPRANKS
·
Mar 14

Capricor selloff today a buying opportunity, says Roth Capital

TIPRANKS
·
Mar 14

Alliance Global Partners Keeps Their Buy Rating on Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 14

Capricor Therapeutics Inc : B. Riley Raises Target Price to $63 From $50

THOMSON REUTERS
·
Mar 13